|Articles|September 23, 2022
Antibody-based drug discovery at the speed of light
Author(s)Curia
The combination of the PentaMice® platform and single B cell screening with the Beacon® system increases speed to market for monoclonal antibody antibody therapeutics.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Mastering Phase-Appropriate Characterization for Biologics Approval
2
Transforming Clinical Bioanalysis for Manufacturing Scalability
3
A Scientifically Justified Agitation Stress Model for Early-Stage Biologics
4
